Construct: ORF ccsbBroadEn_11442
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF018156.1_s300c1, BRDN0000386947
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- PTBP3 (9991)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 9991 | PTBP3 | polypyrimidine tract bindin... | NM_001244898.1 | 100% | 100% | |
2 | human | 9991 | PTBP3 | polypyrimidine tract bindin... | XM_011519265.1 | 99.4% | 99.4% | 136_144delGGTGTGTAT |
3 | human | 9991 | PTBP3 | polypyrimidine tract bindin... | NM_005156.7 | 97.5% | 96.9% | (many diffs) |
4 | human | 9991 | PTBP3 | polypyrimidine tract bindin... | NM_001163790.2 | 97% | 96.4% | (many diffs) |
5 | human | 9991 | PTBP3 | polypyrimidine tract bindin... | XM_006717346.1 | 93.3% | 93.3% | 0_1ins111 |
6 | human | 9991 | PTBP3 | polypyrimidine tract bindin... | NM_001163788.3 | 92.8% | 92.8% | 0_1ins111;25_33delGGTGTGTAT |
7 | human | 9991 | PTBP3 | polypyrimidine tract bindin... | NM_001244897.2 | 85.5% | 82.4% | (many diffs) |
8 | human | 9991 | PTBP3 | polypyrimidine tract bindin... | NM_001244896.2 | 81.7% | 81.7% | 0_1ins304;2delT |
9 | human | 9991 | PTBP3 | polypyrimidine tract bindin... | XM_024447722.1 | 81.7% | 81.7% | 0_1ins304;2delT |
10 | human | 9991 | PTBP3 | polypyrimidine tract bindin... | XM_017015365.1 | 81% | 81% | 0_1ins318 |
11 | mouse | 230257 | Ptbp3 | polypyrimidine tract bindin... | NM_144904.2 | 89.2% | 92.1% | (many diffs) |
12 | mouse | 230257 | Ptbp3 | polypyrimidine tract bindin... | XM_006537852.3 | 88.7% | 91.6% | (many diffs) |
13 | mouse | 230257 | Ptbp3 | polypyrimidine tract bindin... | XM_006537851.3 | 88.3% | 91.4% | (many diffs) |
14 | mouse | 230257 | Ptbp3 | polypyrimidine tract bindin... | XM_006537854.3 | 85.2% | 88.8% | (many diffs) |
15 | mouse | 230257 | Ptbp3 | polypyrimidine tract bindin... | NM_178164.3 | 84.7% | 88.3% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 1740
- ORF length:
- 1674
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaaCTTTG TACAAAAAAG 61 TTGGCATGGA CGCTTCCCCC TCACCTTTCT CTCTCCCCAA GAAACTTAAT GAATTATCTG 121 CCCGTCGGGG ATCTGATGAG CTTCTTTCTT CTGGCATCAT TAACGGACCT TTTACCATGA 181 ATAGTTCTAC TCCTTCTACA GCTAATGGGA ATGACAGCAA GAAATTTAAA CGAGATAGAC 241 CTCCCTGTTC GCCTTCCCGT GTTCTCCATC TTCGAAAAAT TCCATGTGAT GTCACCGAAG 301 CAGAGATCAT ATCATTAGGT CTACCATTTG GCAAAGTAAC TAATCTTTTG ATGTTGAAAG 361 GAAAAAGCCA GGCTTTCTTA GAAATGGCTT CTGAGGAAGC TGCCGTTACT ATGGTGAATT 421 ATTACACTCC TATTACTCCT CACCTTCGAA GCCAGCCTGT TTATATTCAG TATTCCAATC 481 ACAGAGAACT TAAGACTGAC AATCTACCTA ATCAAGCTCG AGCCCAAGCT GCACTGCAGG 541 CTGTCAGTGC CGTCCAATCA GGAAGCCTGG CCCTTTCTGG AGGTCCTTCC AATGAAGGCA 601 CAGTCCTACC TGGGCAGAGC CCTGTGCTTC GAATAATTAT TGAAAACCTC TTTTACCCTG 661 TTACCCTGGA AGTTCTTCAT CAGATATTTT CTAAATTTGG CACAGTCTTG AAGATTATCA 721 CCTTTACAAA GAATAATCAG TTTCAAGCCT TGCTTCAGTA TGCTGACCCA GTAAATGCAC 781 ATTATGCCAA AATGGCTCTG GATGGCCAGA ATATCTATAA TGCATGCTGC ACTCTGCGCA 841 TTGACTTCTC CAAGCTCACC AGCCTTAATG TGAAATATAA TAATGACAAA AGCAGAGACT 901 TCACTCGCTT AGACCTTCCT ACTGGTGATG GCCAGCCATC CCTTGAACCC CCTATGGCTG 961 CTGCTTTTGG TGCACCGGGT ATAATTTCTT CACCATATGC AGGGGCTGCT GGATTTGCCC 1021 CAGCCATTGG ATTTCCTCAA GCTACAGGTC TATCAGTTCC AGCTGTTCCT GGAGCTCTTG 1081 GTCCTCTCAC AATCACCTCT TCTGCTGTCA CTGGAAGGAT GGCCATTCCT GGGGCTAGTG 1141 GTATACCAGG AAATTCTGTT CTACTCGTCA CAAATCTCAA TCCTGATCTT ATCACACCAC 1201 ATGGGCTTTT TATCCTATTT GGAGTCTATG GTGATGTACA TCGAGTGAAG ATTATGTTTA 1261 ATAAGAAAGA AAATGCCTTG GTTCAGATGG CGGATGCAAA TCAAGCTCAG CTAGCAATGA 1321 ACCATCTAAG TGGTCAGAGA CTTTATGGGA AAGTGCTTCG TGCTACACTG TCCAAACATC 1381 AAGCAGTACA GCTTCCTCGA GAGGGACAAG AAGACCAAGG TCTGACTAAG GATTTCAGCA 1441 ATAGTCCTTT GCATCGCTTT AAAAAGCCGG GCTCTAAAAA CTTCCAGAAT ATCTTTCCAC 1501 CATCAGCCAC TCTGCATCTT TCCAACATTC CCCCTTCTGT TACAGTGGAT GATCTGAAGA 1561 ACCTTTTCAT AGAAGCTGGA TGTTCAGTGA AGGCTTTTAA ATTCTTTCAG AAAGATCGCA 1621 AAATGGCGCT CATTCAATTG GGATCTGTGG AAGAAGCAAT TCAGGCCCTC ATTGAGCTTC 1681 ATAACCATGA CCTTGGAGAA AATCACCACC TCAGAGTTTC CTTCTCAAAA TCTACAATCT 1741 GCCCAACTTT CTTGTACAAA GTtggcatta taagaaagca ttgcttatca atttgttgca 1801 acgaac